“…V1V2-glycan bnAbs, such as the PG9, CH01, PGT145 and CAP256-VRC26 lineages, are characterized by anionic, often tyrosine-sulfated, long and protruding CDR H3s that penetrate HIV envelope glycans and recognize a discontinuous epitope at the apex of the HIV-1 spike (14, 15,19,22,25,51–54). Crystal structures in complex with a scaffolded V1V2 domain were solved for PG9, PG16 (in the PG9 lineage) (51, 52), and CH03, CH04 (in the CH01 lineage) (55). V1V2 glycan bnAbs recognize a discontinuous epitope around an N-linked glycan at position 160, with a preference for short high mannose glycans, e.g.…”